To evaluate the pharmacokinetics and safety of nolasiban
RPN-NLS01
Phase 1 other active
Quick answer
To evaluate the pharmacokinetics and safety of nolasiban for not applicable (submitted trial is a pharmacokinetic study in healthy subjects) is a Phase 1 program (other) at Novo mesto with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo mesto
- Indication
- not applicable (submitted trial is a pharmacokinetic study in healthy subjects)
- Phase
- Phase 1
- Modality
- other
- Status
- active